Sunday, 15 August 2021

Urgent New Crypto Alert – BUY BUY BUY

Urgent New Crypto Alert BUY BUY BUY

Silicon Valley millionaire Jeff Brown called it in 2014, when he first bought Bitcoin.

In 2015, he called it again, when he publicly recommended Bitcoin at $240...

In 2016, he recommended Nvidia at $25... before it hit $799... and he predicted the #1 returning tech stock in 4 years out of 5...

In 2017, he called it again – when he recommended Bitcoin again along with two other cryptocurrencies, which have since soared as high as 924.3%...

Now he believes THIS could be his most profitable public recommendation to date!

Stockguru LLC
711 SW 24th Ave Boynton, Beach, FL 33435

This email is being sent from Investing Chatter.
If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.
DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

No comments:

Post a Comment

Breaking News Hits Wire: TC BioPharm (NASDAQ: TCBP) Makes Approx 189% Early Move

  *Sponsored After an Approximate 1,041% Move in Under 3 Months From a Recent BioPharma Profile, Ou...